{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:30"], "contactPoint": {"@type": "vcard:Contact", "fn": "SAMHSA", "hasEmail": "mailto:SAMHSAInfo@samhsa.hhs.gov"}, "description": "Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3) the identification of drugs new to DAWN\u2019s Drug Reference Vocabulary.https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP22-07-03-001.pdf", "distribution": [{"@type": "dcat:Distribution", "description": "Visit the original government dataset for complete information, documentation, and data access.", "downloadURL": "https://www.samhsa.gov/data/report/dawn-2021-preliminary-findings-report", "mediaType": "text/html", "title": "Official Government Data Source"}], "identifier": "https://healthdata.gov/api/views/tidz-vkj5", "issued": "2025-07-14", "keyword": ["drug-related-ed-visits", "emergency-department", "polysubstance-use", "samhsa", "substance-abuse"], "landingPage": "https://healthdata.gov/d/tidz-vkj5", "modified": "2025-09-06", "programCode": ["009:061"], "publisher": {"@type": "org:Organization", "name": "Substance Abuse and Mental Health Services Administration"}, "theme": ["SAMHSA"], "title": "Preliminary Findings from Drug-Related Emergency Department Visits, 2021"}